Search for: "WORD v. PFIZER, INC. et al"
Results 1 - 20
of 24
Sorted by Relevance
|
Sort by Date
11 Aug 2010, 9:43 am
" Pfizer Inc. et al v. [read post]
16 Jul 2015, 4:00 am
Gould et al. (1983), 70 C.P.R. (2d) 11 (FCA). [read post]
14 Mar 2023, 11:48 pm
Pfizer, Inc., 2009 WL 3320272, at *2 (N.D. [read post]
30 Nov 2015, 3:34 am
Never Too Late 70 [week ending on Sunday 1 November] – Case T-309/13 Enosi Mastichoparagogon Chiou v OHIM, Gaba International Holding GmbH | Sixteen millions IPKats | Tomaydo-Tomahhdo LLC v George Vozray et al | Lookalike packaging | Parasite copying | 3D printing | Labouring the point? [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
12 Oct 2011, 8:31 am
See Perfect 10, Inc. v. [read post]
14 Mar 2013, 4:00 am
” otherwise “. . . the court may be heading into unknown waters without a chart.[429] An example of an application of this reading of Free World can be found in Pfizer Canada Inc. v. [read post]
3 Mar 2012, 5:36 pm
Minn. 2008)(noting that some but not all courts have concluded relative risks under two support finding expert witness’s opinion to be inadmissible) XYZ, et al. v. [read post]
5 Mar 2010, 9:10 pm
Pfizer, Inc. v. [read post]
18 Mar 2011, 10:04 am
Pfizer, 196 F. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
14 Jun 2013, 12:13 pm
Pfizer, 196 F. [read post]
23 Jan 2013, 1:02 am
United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Argued October 16, 2012 Decided January 22, 2013 No. 11-1265 AMERICANS FOR SAFE ACCESS, ET AL., PETITIONERS v. [read post]
23 Jan 2013, 1:02 am
United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Argued October 16, 2012 Decided January 22, 2013 No. 11-1265 AMERICANS FOR SAFE ACCESS, ET AL., PETITIONERS v. [read post]
5 Jun 2013, 5:29 am
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
25 Apr 2015, 11:03 am
See also Manual at 614 n. 198., citing Ofer Shpilberg, et al., The Next Stage: Molecular Epidemiology, 50 J. [read post]
29 Dec 2010, 12:54 pm
Wyeth, Inc. v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
13 Apr 2014, 8:59 am
Sanofi-Synthelabo Canada Inc., [2008] 3 SCR 265 At the outset, it is appropriate to refer to the words of Judson J. for this Court in Commissioner of Patents v. [read post]
4 Apr 2008, 1:00 am
, (Ars Technica), (Patent Prospector), (Washington State Patent Law Blog), (IP Law Observer), (PLI), (PLI), (IP Updates), (Patent Docs), (Peter Zura’s 271 Patent Blog), (The Invent Blog), (IP Spotlight), (Just a Patent Examiner), (Techdirt), (Patent Baristas), (IPBiz), (IPBiz), (Patently-O), (IAM), (IP ThinkTank), (Against Monopoly), (Against Monopoly), (IP Law360), (Hal Wegner), (Ladas & Parry), Global Global - General Virtual monopoly – four strategic choices:… [read post]
